Tag: FreeStyle Libre

ABBOTT PARK, Ill. – Abbott has received approval from the Japanese Ministry of Health, Labour and Welfare for expansion of reimbursement coverage for its FreeStyle Libre system to include all people with diabetes who use insulin at least once a day. The expanded coverage will enable more people with diabetes to access the glucose data needed to manage their condition without the routine fingersticks associated with traditional blood glucose monitoring. "The best health care solution is the...

ABBOTT PARK, Ill. - Abbott has received Food and Drug Administration clearance for its Freestyle Libre 2. The Libre 2 continuously transmits glucose data every minute, and users can set the system to send alarms for too-high or too-low readings. Previously, users had to scan the sensor to get a reading. The system, which is offered at the same price point as the previous version of the Freestyle Libre, will become available in the next several weeks. The FreeStyle Libre was approved for Medicare...

“How 'bout those CGMs?" I was at the doctor's office today—not the endo's—and the nurse was double-checking I still used the Freestyle Libre. Turns out, she has a Dexcom. I've said it before in this forum: the advances in diabetes tech are game changers. They have forever changed the way diabetes is managed. End game: more time in range (this is a fairly new concept), better AICs. I discussed this recently with several diabetes providers for a recent story on Walgreens entering...

When last year's Heartland Conference rolled around, I had just gotten my Freestyle Libre and was excited to take it on the road and see how much easier it was to check my blood sugar from the confines of a plane or during a session. Unfortunately, I knocked it off two days prior, courtesy of a doorframe that came at me out of nowhere (rookie mistake). Insurance policies being what they are, I had no way to replace before I took off, alas. Fast forward to this year's event and I can report that yes,...

ABBOTT PARK, Ill. - Abbott and Novo Nordisk have partnered to integrate insulin dose data from Novo Nordisk's connected insulin pens with digital health tools compatible with Abbot's FreeStyle Libre continuous glucose monitoring system. The integration will allow healthcare professionals, caregivers and patients to view glucose and insulin data together to help them make better informed treatment decisions, according to a press release. "It is our aim at Abbott to continuously provide life-changing...

As I was sitting down at my desk one recent morning my coworker, Cath, came to me and said, “Theresa, I guess I need to ask you about diabetes.” Being short on coffee and a bit long on self-centeredness, I blinked in confusion, thinking she meant MY diabetes. But, since I've worked with her for years and already demoed my new-ish Freestyle Libre to the office (and my mom, my friends and my doctor), this made no sense. She was actually trying to drum up the contact list for our November...

ABBOTT PARK, Ill. - The U.S. Food and Drug Administration has approved Abbott's FreeStyle Libre 14-day Flash Glucose Monitoring System. The system has a one-hour warm-up period, compared to 12 hours with the FreeStyle Libre 10-day system, which received FDA approval in September 2017. The Libre is the No. 1 continuous glucose monitoring device in the world, with more than 800,000 users in more than 43 countries, according to a press release. It was approved for Medicare coverage in January.

WASHINGTON - CMS will allow Medicare beneficiaries to use smart phone technology with their continuous glucose monitors, it announced.The announcement reverses guidance issued in March 2017 in which the agency said beneficiaries could not use a non-DME device, such as a smart phone or tablet as the display device—in conflict with how many use their CGMs.“CMS heard from numerous stakeholders who shared their concerns that Medicare's CG coverage policy limited their use of CGMs in conjunction...

ABBOTT PARK, Ill. - The FreeStyle Libre System is the second continuous glucose monitoring system approved for Medicare coverage. The Abbott-manufactured system requires no user calibration, reading glucose levels via a sensor worn on the upper arm. Users simply wave a reader over the sensor to get a reading. CMS in early 2017 approved certain CGMs as DME as long as they are approved by the Food and Drug Administration for use in place of a blood glucose monitor for making treatment decisions. The...